Dyadic International Inc (DYAI) Financial Statements
Industry: Biological Products, (No Diagnostic Substances)
In fiscal 2025, Dyadic International reported revenue of $3.1M, down 11.6% from $3.5M the year before. Net income was -$7.4M (a -238.3% net margin), or -$0.23 per diluted share. Gross margin was 24.9% and operating margin was -232.8%. Operating activities generated -$5.7M of cash. At fiscal year end, Dyadic International held $9.9M in total assets against $8.7M in total liabilities, including $4.6M of cash and equivalents.
Open the full interactive Dyadic International financials → Quarterly statements, key ratios, valuation history and price charts.
Dyadic International Key Stats
| Share Price | $0.43 |
|---|---|
| Market Cap | $15.7M |
| Revenue YoY Growth | -11.6% |
| 52-Week Range | $0.40 – $1.47 |
| Shares Outstanding | 36.4 million (basic, 2026 Q2) |
Dyadic International Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $1.6M | $2.4M | $2.9M | $2.9M | $3.5M | $3.1M |
| Cost of Goods Sold | $1.4M | $1.9M | $2.1M | $2.0M | $1.2M | $2.3M |
| Gross Profit | $176,990 | $459,393 | $807,110 | $922,957 | $2.3M | $770,485 |
| Operating Income | -$10.0M | -$14.7M | -$10.2M | -$8.2M | -$5.9M | -$7.2M |
| Pre-Tax Income | -$9.3M | -$13.1M | -$9.7M | -$6.8M | -$5.8M | -$7.4M |
| Income Tax | $31,318 | $0 | — | — | — | — |
| Net Income | -$9.3M | -$13.1M | -$9.7M | -$6.8M | -$5.8M | -$7.4M |
| Diluted EPS | -$0.34 | -$0.47 | — | — | — | -$0.23 |
Dyadic International Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $1.2M | $565,526 | $1.1M | $961,138 |
| Net Income | -$2.0M | -$1.6M | -$2.0M | -$2.1M |
| Diluted EPS | -$0.06 | -$0.05 | -$0.05 | -$0.06 |
Dyadic International Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $20.6M | $15.7M | $5.8M | $6.5M | $6.5M | $4.6M |
| Current Assets | $29.8M | $21.0M | $13.4M | $8.1M | $9.8M | $9.9M |
| Total Assets | $30.1M | $21.3M | $13.7M | $8.2M | $9.9M | $9.9M |
| Current Liabilities | $1.6M | $2.6M | $2.4M | $2.3M | $2.4M | $3.7M |
| Total Liabilities | $1.6M | $2.9M | $2.6M | $2.3M | $7.5M | $8.7M |
| Shareholders' Equity | $28.4M | $18.4M | $11.1M | $5.9M | $2.5M | $1.2M |
Dyadic International Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | -$6.6M | -$11.3M | -$8.1M | -$6.7M | -$4.0M | -$5.7M |
| Cash From Investing | $22.1M | $5.2M | -$2.4M | $7.4M | -$1.9M | $82,085 |
| Cash From Financing | $255,470 | $1.2M | $543,591 | $0 | $5.8M | $5.0M |
Figures from Dyadic International's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Dyadic International financials page for every line item.
Dyadic International Company Profile
| Ticker | DYAI |
|---|---|
| Exchange | Nasdaq |
| Industry | Biological Products, (No Diagnostic Substances) |
| Headquarters | Jupiter, Florida |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Non-accelerated filer, smaller reporting company |
| SEC CIK | 0001213809 |
Frequently Asked Questions
What was Dyadic International's revenue in fiscal 2025?
Dyadic International (DYAI) reported revenue of $3.1M for fiscal 2025.
What is Dyadic International's annual revenue history?
Dyadic International's annual revenue by fiscal year: 2020: $1.6M; 2021: $2.4M; 2022: $2.9M; 2023: $2.9M; 2024: $3.5M; 2025: $3.1M.
What was Dyadic International's net income in fiscal 2025?
Dyadic International reported net income of -$7.4M for fiscal 2025.
What was Dyadic International's earnings per share (EPS) in fiscal 2025?
Dyadic International's diluted EPS was -$0.23 for fiscal 2025 (adjusted for any later stock splits).
What was Dyadic International's revenue last quarter?
In its most recent reported quarter (2026 Q2), Dyadic International reported revenue of $961,138.
How many shares of Dyadic International are outstanding?
Dyadic International reported a weighted average of 36.4 million basic shares outstanding in 2026 Q2.
What is Dyadic International's market cap?
Based on its latest closing price, Dyadic International (DYAI) has a market capitalization of about $15.7M.
When does Dyadic International's fiscal year end?
Dyadic International's fiscal year end, as registered with the SEC, is December 31.
Where is Dyadic International headquartered?
Dyadic International lists its business address in Jupiter, Florida in its SEC filings.
Dyadic International Competitors & Similar Companies
See all 136 Biological Products, (No Diagnostic Substances) companies →